Virtual Reality-Supported Exercise for Chronic Musculoskeletal Shoulder Disorders: a Feasibility Study
V-RECS
1 other identifier
interventional
20
1 country
1
Brief Summary
People with long-term (chronic) shoulder disorders caused by injuries, overuse or conditions (such as arthritis) often need physiotherapy. This usually includes exercise therapy to help reduce pain, rebuild strength and make every day activities easier. However, it can be hard to stick to an exercise programme. People may stop due to pain, fear of making the symptoms worse or simply loosing motivation. Virtual Reality (VR) is a technology that may help people say engaged with their exercise programmes by making exercises more enjoyable and interactive. When using a headset (similar to goggles), people can see and interact with a 3D virtual world. Their movement, especially their hands and arms, are shown as an 'avatar' (a virtual character) in this virtual world. Exercise can feel more like playing a game or engaging with tasks/challenges, rather than performing repetitive movements. This shift might help reduce focus on pain and increase motivation. VR also provides real-time feedback, helping people track their progress and adjust their movements instantly. This might lead to more accurate and consistent exercise performance and better recovery outcomes. Before we can test whether VR exercise programmes are effective for people with chronic shoulder disorders, we firstly need to understand whether it is practical and acceptable for patients to use. This 'feasibility' study will therefore involve 20 patients with chronic shoulder disorders referred for physiotherapy at the Royal National Orthopaedic Hospital (RNOH) in Stanmore, United Kingdom. Participants will take part in three VR exercise sessions at the RNOH over a three-week period. Levels of pain, quality of life and sleep quality etc. will be measured before and after three weeks. Interviews will also be held up to two weeks after the final session to explore people's experiences and thoughts towards the VR exercise programme. The results will help us decide if a larger study should go ahead.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2026
CompletedStudy Start
First participant enrolled
January 16, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 6, 2026
October 1, 2025
10 months
January 15, 2026
January 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Consent rate
The consent rate will be used as a measure of recruitment and will be defined as the number of participants who provide informed consent divided by the total number of patients screened for eligibility, ie: number of people who consented/number of people approached) x 100.
During enrolment period
Dropout rate
The dropout rate will be defined as the percentage of participants who started the study, but did not complete all three treatment visits.
From first treatment visit though completion of treatment (average of 3 weeks)
Secondary Outcomes (8)
Pain Intensity - Numeric Pain Rating Scale (NPRS)
* Baseline (Pre-intervention), * Immediately before and after each treatment session (up to 3 visits), * One follow-up 1 visit (within 48 hours of the last treatment session, average of 3 weeks)
Shoulder Range of Movement
Baseline (pre-intervention) and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks).
Disability - Shoulder Pain and Disability Index (SPADI)
Baseline (pre-intervention) and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks).
Quality of Life - EuroQol- 5 Dimension (EQ-5D-3L)
Baseline (pre-intervention) and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks).
Sleep Quality - Pittsburgh Sleep Quality Index (PSQI)
Baseline (pre-intervention) and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks).
- +3 more secondary outcomes
Study Arms (1)
Virtual Reality Exercise Programme
EXPERIMENTALConsenting participants will attend three VR exercise sessions delivered by an upper limb physiotherapist at the Royal National Orthopaedic Hospital (RNOH), using the SyncVR FIT platform. The SyncVR FIT platform is designed to support unilateral or bilateral upper limb movement through a series of interactive games, tasks, and challenges delivered via a VR headset. Participants will use handheld controllers to engage with these activities, enabling the system to track upper limb motion. While wearing the headset, participants will see a virtual representation of their upper limbs-specifically their hands-within the VR environment. These virtual hands mirror the participants' real-time movements, enhancing the sense of immersion and embodiment. A tablet device will be used by the intervention provider to monitor the session.
Interventions
Participants will engage with a 30 minute shoulder exercise programme using the SyncVR platform. There will be three intervention sessions in total and they will be spaced out once per week for a period of three weeks.
Eligibility Criteria
You may qualify if:
- Adult patients \>18 years with diagnosed unilateral/ bilateral shoulder pain with/ without co-existing symptoms of instability and or stiffness (persisting \> three months) generated from a Musculoskeletal origin
- Patients who have been referred for conservative management
- New or follow-up patients
- Sufficient English to understand written materials/verbal instruction/or accompanied by family/friends able to translate
- Patients who provide informed, written consent to enter the study
You may not qualify if:
- Unable to provide informed consent
- On a waiting list for surgery and/or injections
- Referred for post-operative physiotherapy
- Shoulder pain not originating from an MSK aetiology (such as hemiplegia or peripheral nerve injury)
- Active history of seizures
- Other relevant medical conditions deemed inappropriate for patients to participate e.g. visual impairment, unstable psychiatric illnesses.
- Shoulder pain associated with bone metastasis
- Currently taking part in any other upper limb research study
- Patients who do not adequately understand verbal explanations or written information given in English (or are not accompanied by an interpreter/family member).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Royal National Orthopaedic Hospital NHS Trustlead
- SyncVR Medicalcollaborator
Study Sites (1)
Royal National Orthopaedic Hospital
Middlesex, London, HA74LP, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anju Jaggi, MSc
Royal National Orthopaedic Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2026
First Posted
February 6, 2026
Study Start
January 16, 2026
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 6, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share